Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Off-Label Enforcement, Not Promotion, May See First Changes After Free Speech Ruling

This article was originally published in The Gray Sheet

Executive Summary

In a watershed decision, a federal appeals court declares that manufacturers cannot be prosecuted under the Federal Food, Drug & Cosmetic Act’s misbranding provisions solely for speech promoting off-label use. Industry attorneys predict the decision, if it stands, will change the government’s approach to pursuing such cases.

You may also be interested in...



News In Brief

News on DePuy hip liability suits, U.S. v. Caronia and more.

DOJ Unlikely To Take Off-Label Promotion Case To Supreme Court, Attorneys Say

The recent appellate court case U.S. v. Caronia was viewed as a victory for pharmaceutical companies in terms of truthful, off-label promotion, and as the government assesses its next move, attorneys project the case won’t make it to the Supreme Court.

Off-Label Questions, Online: FDA Explains How To Handle Them

FDA draft guidance weighs in on web communications, saying that firms must answer off-label-information questions privately, even if the questions arise in a public online forum.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031794

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel